The term “allergy” is often used ambiguously, frequently applied to a broad spectrum of immune and non-immune reactions, which can create confusion in clinical practice. Whilst there is some controversy, the term “allergy” is now primarily reserved for describing immunoglobulin E (IgE)-mediated (Type I) hypersensitivity. Accurate diagnosis requires distinguishing Type I reactions from their mimics, especially given the clinical overlap with non-IgE-mediated conditions. This review focuses on Type I hypersensitivity, detailing its immunopathogenesis, clinical features, and diagnostic strategies, with particular emphasis on the role of serum tryptase in confirming mast cell activation. A comprehensive clinical history is crucial to distinguishing IgE-mediated allergy from its mimics, focusing on timing, symptom reproducibility, and the identification of potential triggers. Cofactors like non-steroidal anti-inflammatory drugs, alcohol, and exercise may exacerbate reactions, complicating diagnosis. Prompt intramuscular adrenaline administration is essential in cases of anaphylaxis, while patient education and specialist referral are key to long-term management. The review also examines conditions that may mimic Type I reactions, such as chronic spontaneous urticaria or isolated angioedema. In addition to classical allergy, clinicians must consider conditions such as hereditary angioedema, neuroendocrine tumours, and drug-induced pseudoallergic reactions. Recognising these mimics is vital to prevent misdiagnosis, ensuring patient safety, and avoiding unnecessary allergy labels or suboptimal management. This article provides a structured framework for evaluating suspected allergy, enhancing diagnostic accuracy, and guiding appropriate, patient-centred care across allergy and related clinical disciplines.
Johnston et al. (Wed,) studied this question.